Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation declines year over year

Q3 FY2026 stock-based compensation of $2.95M fell 1.5% year over year, ahead of the -31.7% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 6.0% from the prior quarter.

Context

  • Stock-based compensation amounted to 5.4% of revenue in FY2025, down 3.8 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -1.5% holds above the trailing-twelve-month pace of -31.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.95M-6.0% QoQ
Last fiscal yearDec 2025
-$11.42M-174.3% YoY
LTMSep 2026
$6.28M-31.7% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.5%——
1 year-174.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
(11.42M) USD
Year-over-year change
-174.3%

Stock-Based Compensation vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 stock-based compensation of $6.28M is the 2nd largest of the 4 companies compared; the peer median is $3.2M.
  • Its year-over-year change of -31.7% is the 3rd highest of 4, against a peer median of -23.9%.
  • Stock-based compensation amounts to 2.4% of revenue for ESTA, versus a peer median of 1.3%.
ESTA Competitors Peer median
Stock-Based Compensation for ESTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$21.88M +6.0%-12.5%1.3%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$6.28M -31.7%—2.4%
TELATELA Bio, Inc.LTM Jun 2026$3.2M -23.9%-1.6%4.0%
INMDInMode Ltd.LTM Mar 2026$2.5M -77.5%-23.1%0.7%
Peer median (excluding ESTA) $3.2M-23.9%-12.5%1.3%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
Deferred Income Tax7K86K(3.71M)(2.18M)6.96M
Stock-Based Compensation10.41M13.36M14.86M15.37M(11.42M)
Change in Working Capital(6.44M)(21.54M)(34.13M)(15.5M)(13.17M)
Accounts Receivables(6.7M)(12.33M)(11.56M)(26.28M)(11.47M)
Inventory(7.64M)(10.9M)(42.23M)(471K)(7.06M)
Accounts Payables4.96M4.38M18.96M6.67M(2.3M)
Other Working Capital2.94M(2.69M)701K4.58M7.65M
Other Non-Cash Items5.51M26.8M8.08M20.81M7.33M
Operating Cash Flow(27.53M)(52.17M)(88.51M)(58.52M)(50.89M)
Capital Expenditures(6.73M)(34.27M)(24.55M)(15.56M)(6.72M)
Acquisitions (Net)000(50K)(307K)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(434K)(525K)(16.64M)(9.45M)(672K)
Investing Cash Flow(7.16M)(34.79M)(24.55M)(15.61M)(7.03M)
Debt Repayment(175K)96.39M024.47M33.48M
Common Stock Issued4.58M3.87M84.54M99.48M7.59M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(356K)(4K)1.69M1.94M(637K)
Financing Cash Flow4.05M100.26M86.23M125.9M40.43M
Effect of Forex Changes(465K)(358K)513K(1.46M)2.71M
Net Change in Cash(31.11M)12.94M(26.32M)50.31M(14.78M)
Free Cash Flow(34.26M)(86.43M)(113.06M)(74.08M)(57.61M)

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.